2017

Equity Research Report: Telekomunikasi Indonesia 3Q17

Read better with the PDF file: TKM Report Telkom Indonesia: Cheap Valuation Despite Strong Performance Recommendation: BUY Target Price : Rp 5.580 Closing Price : Rp 4440 Upside (Downside) Potential : +25.8% Company Profile PT Telekomunikasi Indonesia Tbk offers telecommunications and network services. The Company’s segments include Corporate, Home, Personal and Others. TheContinue reading “Equity Research Report: Telekomunikasi Indonesia 3Q17”

Relationship Between US Economic Indicator and Its Impact on Gold Price

Download the PDF Files with Graph: US Economic Indicator and its impact on Gold Price Saturday, December 29th 2017 This article is written to enhance the understanding of relationships between US monthly economic data and as a groundwork for my currency trade. The main goal is to find if difference in timing of the economic dataContinue reading “Relationship Between US Economic Indicator and Its Impact on Gold Price”

Equity Research Report: Metrodata Electronics 3Q17

Download the Report in PDF: MTDL Report METRODATA ELECTRONICS Tbk: Valuation MTDL.IJ (Indonesian Equity) Recommendation: BUY Target Price : Rp 930 Closing Price : Rp 595 Upside (Downside) Potential : 57.0% Company Profile PT Metrodata Electronics Tbk is an Indonesia-based information technology company. It is engaged in the provision of IT productsContinue reading “Equity Research Report: Metrodata Electronics 3Q17”

Equity Research Report: Emergent Biosolutions 3Q17

Download the Report in PDF: EBS Report Download the Valuation in Excel: Emerging Biosolutions Valuation Emergent Biosolutions Inc.: 3Q17 Recommendation: BUY Target Price : $49.86 Closing Price : $40.86 Upside (Downside) Potential : 22.0% Company Profile Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the body’s immuneContinue reading “Equity Research Report: Emergent Biosolutions 3Q17”

Equity Research Report: Addus HomeCare 3Q17

Download the Report in PDF: ADUS Report Download the Excel Model: ADUS Valuation Addus HomeCare Corp: Maintaining Growth Momentum Recommendation: OUTPERFORM Target Price : $37.78 Closing Price : $32.55 Upside (Downside) Potential : +16.1% Company Profile Addus HomeCare Corporation provides a broad range of social and medical services in the home. The company’sContinue reading “Equity Research Report: Addus HomeCare 3Q17”